News | October 17, 2011

CDC Reports Uneven Declines in Coronary Heart Disease by State and Race/Ethnicity

October 17, 2011 – The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention (CDC).

From 2006 to 2010, the number of people in the United States who report they have been told by a health professional they have coronary heart disease declined overall from 6.7 percent to 6 percent. The data came from CDC?s Behavioral Risk Factor Surveillance System (BRFSS), a phone survey conducted each year of adults aged 18 and older.

The report attributes the decline to a combination of reductions in prevalence of high-risk populations for heart disease such as smokers, patients with uncontrolled high blood pressure, and uncontrolled high blood cholesterol along with improvements in treatments for heart disease.

Despite that decline, cardiovascular disease remains the leading cause of death in the United States killing roughly the same number of Americans each year as cancer, lower respiratory diseases (including pneumonia) and accidents combined.

The highest rates of self–reported coronary heart disease are among older adults aged 65 and older (19.8 percent) and American Indians/Alaskan Natives (11.6 percent).

The report also notes geographic differences in self–reported coronary heart disease. In 2010, coronary heart disease prevalence ranged from lows of 3.7 percent in Hawaii and 3.8 percent in the District of Columbia to highs of 8 percent in West Virginia and 8.2 percent in Kentucky. Generally, populations in Southern states reported the highest levels of coronary heart disease.

“Where you live and how you live matters to your heart,” said CDC Director Thomas R. Frieden, M.D., M.P.H . “The Million Hearts national initiative, which can prevent 1 million heart attacks and strokes over the next five years, focuses on actions people can take themselves and actions that businesses, communities and health providers can take to prevent heart attacks and strokes today.”

Million Hearts seeks to improve clinical care by helping patients learn and follow their ABCS:

  • Aspirin for people at risk
  • Blood pressure control
  • Cholesterol management
  • Smoking cessation

Fewer than half of Americans who should be taking an aspirin a day are taking one; fewer than half of Americans with high blood pressure have it under control.  Only 1 in 3 Americans with high cholesterol is effectively treated, and less than a quarter of Americans who smoke get help to quit when they see their doctor.

 “We're all at risk for heart disease and stroke,” said Jing Fang, M.D., epidemiologist with CDC?s Division of Heart Disease and Stroke Prevention. “People of all ages, genders, races, and ethnicities are affected. However, certain groups, including American Indians/Alaskan Natives, African-Americans and older adults, are at higher risk than others.”

The MMWR report on state coronary heart disease prevalence is available at www.cdc.gov/mmwr

 

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init